Tuberculosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be 18 years of age or older
- You must have been diagnosed with a type of tuberculosis (TB) that does not respond to the antibiotic rifampicin, confirmed by a lab test
- You must have started a TB treatment plan that includes the medication linezolid no more than 14 days before joining the trial
- Your HIV status must be known — both people who are HIV-positive and HIV-negative are welcome to join
- If your HIV status is unknown, you must agree to take an HIV test at the time of enrollment to be eligible
Who may not be able to join:
- You may not be able to join if you have a serious medical condition where doctors expect you may not survive the next 7 days
- You may not be able to join if you are pregnant at the time of screening
- You may not be able to join if your starting dose of linezolid is less than 600mg per day
- You may not be able to join if you have a severe form of TB that has spread outside the lungs to areas such as the brain lining, the heart lining, or the bones
- You may not be able to join if it is unlikely that you would be able to attend follow-up appointments at Nkqubela Hospital based on where you live
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: James CM Brust, MD, Albert Einstein College of Medicine
Phone: 718-920-6482
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Discontinuation of Linezolid or non-TDM guided dose reduction
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.